blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2396326

EP2396326 - SPIROINDOLINONE PYRIDINE DERIVATIVE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.04.2013
Database last updated on 02.09.2024
Most recent event   Tooltip12.04.2013Application deemed to be withdrawnpublished on 15.05.2013  [2013/20]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2011/51]For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / CHEN, Li
Dongjiao State Guest Hotel A18
No. 1800 Jinke Road
Shanghai 201203 / CN
02 / HAN, Xingchun
Lane 631, Gumeixi Road
Rm 502, No. 201
Shanghai 201102 / CN
03 / YANG, Song
1155 Guanglan Road
Pudong
Shanghai 201210 / CN
04 / ZHANG, Zhuming
59 Wesley Road
Hillsborough New Jersey 08844 / US
 [2011/51]
Representative(s)Beyermann, Jochen Carl
F. Hoffmann-La Roche AG CLP - Patent Department Grenzacherstrasse 124
4070 Basel / CH
[2011/51]
Application number, filing date10701882.202.02.2010
WO2010EP51252
Priority number, dateUS20090151279P10.02.2009         Original published format: US 151279 P
[2011/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010091979
Date:19.08.2010
Language:EN
[2010/33]
Type: A1 Application with search report 
No.:EP2396326
Date:21.12.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 19.08.2010 takes the place of the publication of the European patent application.
[2011/51]
Search report(s)International search report - published on:EP19.08.2010
ClassificationIPC:C07D471/10, A61K31/496, A61P35/00
[2011/51]
CPC:
C07D471/10 (EP,KR,US); A61K31/438 (KR); A61P35/00 (EP);
A61P43/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/51]
TitleGerman:SPIROINDOLINON-PYRIDIN-DERIVATE[2011/51]
English:SPIROINDOLINONE PYRIDINE DERIVATIVE[2011/51]
French:DÉRIVÉ DE SPIROINDOLINONE ET DE PYRIDINE[2011/51]
Entry into regional phase12.09.2011National basic fee paid 
12.09.2011Designation fee(s) paid 
12.09.2011Examination fee paid 
Examination procedure25.06.2010Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.09.2011Examination requested  [2011/51]
28.06.2012Communication of intention to grant the patent
08.11.2012Fee for grant paid
08.11.2012Fee for publishing/printing paid
09.11.2012Application deemed to be withdrawn, date of legal effect  [2013/20]
17.12.2012Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2013/20]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.06.2012
Fees paidRenewal fee
07.02.2012Renewal fee patent year 03
28.02.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]US2007213341  (CHEN LI [CN], et al) [AD] 1-8 * paragraphs [0008] - [0018] *;
 [A]WO2008055812  (HOFFMANN LA ROCHE [CH], et al) [A] 1-8* page 1, line 1 - line 10; claim 1 *;
 [A]  - DING KE ET AL, "Structure-based design of potent non-peptide MDM2 inhibitors", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, NEW YORK, USA, vol. 127, no. 29, ISSN 0002-7863, (20050727), pages 10130 - 10131, (20050630), XP002527584 [A] 1-8 * the whole document *

DOI:   http://dx.doi.org/10.1021/JA051147Z
by applicantUS2007213341
    - J. AM CHEM. SOC., (2005), vol. 127, page 10130
    - ANSEL ET AL., Pharmaceutical Dosage Forms and Drug Delivery Systems, (1995), pages 196,456 - 457
    - TETRAHEDRON, (1999), page 11021
    - J. AM. CHEM. SOC., (1999), page 2617
    - GREENE, T.W. ET AL., Protective Groups in Organic Synthesis, JOHN WILEY & SONS INC.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.